The decrease in S6K1 and AKT phosphorylation upon DEPTOR silencing suggested that the reduction in the levels of ErbB2 by DEPTOR knockdown appears to play a major role in suppressing the PI3K/AKT/mTOR pathway in ErbB2-positive breast cancer cells. Here, ERBB2 is linked to breast carcinoma.